ImmunityBio CEO Dr. Patrick Soon-Shiong discusses the company’s upcoming COVID-19 vaccine trial

The Food and Drug Administration has cleared ImmunityBio to begin testing an experimental COVID-19 vaccine in clinical trials, according to an announcement issued Thursday by the Southern California biotech. U-T biotech reporter Jonathan Wosen and ImmunityBio CEO Dr. Patrick Soon-Shiong discuss how the vaccine works and how the company would produce and distribute it should it prove to be safe and effective.